Update on left ventricular assist devices as a bridge to recovery

Current Opinion in Organ Transplantation

Volumn 6, Issue 3, 2001, Pages 211-215

  Van Meter Jr , Clifford H ^a   Mehra, Mandeep ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ARTICLE; ASSISTED CIRCULATION; AWARENESS; BIOCHEMISTRY; CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DEVICE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART TRANSPLANTATION; HISTOLOGY; HUMAN; HUMAN CELL; HYPOTHESIS; MEDICAL ASSESSMENT; PATHOLOGICAL ANATOMY; POPULATION RESEARCH; PREDICTION; TREATMENT OUTCOME;

EID: 0035703899     PISSN: 10872418     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075200-200109000-00002     Document Type: Article

References (21)

1. Transient normalization of systolic and diastolic function after support with a left ventricular assist device in a patient with dilated cardiomyopathy
2. Bridging to recovery
3. Left ventricular assists system as a bridge to myocardial recovery
4. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure
5. Circulatory support for seventy days with resolution of acute heart failure [case report]
6. Mechanical bridge to recovery in fulminant myocarditis
7. Heart failure
8. Ventricular remodeling: From bedside to molecule
9. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure
10. Regression of cellular hypertrophy after left ventricular assist device support
11. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure
12. Deloading of the left ventricle by ventricular assist device normalizes increased express of endothelin ET (A) receptors but not endothelin-converting enzyme-1 in patients with end-stage heart failure
13. Alterations in Ca2+ cycling protein and G alpha q signaling after left ventricular assist device support in failing human hearts
14. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure
15. Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure
16. Left ventricular assist device implantation augments nitric oxide dependent control of mitochondrial respiration in failing human hearts
17. Altered levels of mRNA of apoptosis-mediating genes after mid-term mechanical ventricular support in dilative cardiomyopathy: First results of the Halle Assist Induced Recovery study (HAIR)
18. Apoptosis, Bcl-2 and proliferating cell nuclear antigen in the failing human heart: Observations made after implantation of left ventricular assist device
19. A new method of monitoring recovery and weaning the Thoratec left ventricular assist device
20. Gene therapy and genomic strategies for cardiovascular surgery: The emerging field of surgiomics
21. Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD